RecruitingNot ApplicableNCT06610474

Evaluation of an Online Prostate Cancer Screening Decision Aid


Sponsor

David Siegel

Enrollment

510 participants

Start Date

Nov 27, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to learn if the online, simulated human "Talk to Nathan About Prostate Cancer Screening" decision aid (https://www.cdc.gov/prostate-cancer/talk-to-nathan/index.html) is effective in helping patients decide about prostate cancer screening. The main questions it aims to answer are: * Is using the "Talk to Nathan About Prostate Cancer Screening" decision aid effective in improving knowledge, overcoming health literacy barriers, and resolving decisional conflict compared to a standard decision aid or standard education materials? * What are the barriers and best practices for incorporating Talk to Nathan About Prostate Cancer Screening into the flow of primary care practice? Researchers will compare "Talk to Nathan About Prostate Cancer Screening" to a standard decision aid and to standard prostate cancer screening education materials to test the effectiveness of using "Talk to Nathan About Prostate Cancer Screening." Participants will: * Use "Talk to Nathan About Prostate Cancer Screening," use a standard decision aid, or use standard education materials about prostate cancer screening * Visit the primary care clinic for follow-up * Complete surveys as part of the clinical trial


Eligibility

Sex: MALEMin Age: 55 YearsMax Age: 69 Years

Inclusion Criteria6

  • Male.
  • Aged 55-69 years.
  • Scheduled for an upcoming health exam.
  • Has access to the internet.
  • Has a valid email address or valid mobile phone number with SMS capabilities.
  • Speaks and reads English or Spanish.

Exclusion Criteria6

  • Refuses to participate.
  • Currently has urinary tract symptoms (i.e., difficulty starting urination; weak or interrupted flow of urine; urinating often, especially at night; trouble emptying the bladder completely; pain or burning during urination; blood in the urine or semen; pain in the back, hips, or pelvis that doesn't go away; or painful ejaculation).
  • Prior history of prostate cancer.
  • Scheduled for, undergoing, or has had a prostate biopsy.
  • A previous PSA score is contained in the patient's health record and it is greater than or equal to 4 ng/mL and/or a very suspicious digital rectal exam (DRE) result (defined as the presence of significant induration, nodularity, or asymmetry).
  • Patient has a terminal illness, significant psychiatric comorbidity (identified by clinic coordinator), cognitive deficits, or reports of ongoing substance misuse.

Interventions

BEHAVIORALUse of the online "Talk to Nathan about Prostate Cancer" decision aid

This decision aid is publicly available at this website in both English or Spanish: https://www.cdc.gov/prostate-cancer/talk-to-nathan/index.html

BEHAVIORALUse of a standard prostate cancer screening decision aid

The standard decision aid is available here and will be used in either English or Spanish: https://massclearinghouse.ehs.state.ma.us/PROG-CANC/CA1382kit.html

BEHAVIORALUse of standard prostate cancer education materials

The standard education materials are available from the National Cancer Institute (NCI) website in English or Spanish: https://www.cancer.gov/types/prostate/patient/prostate-screening-pdq


Locations(4)

East Northport Medical Care

East Northport, New York, United States

Camino

Charlotte, North Carolina, United States

Alliance Medical Ministry

Raleigh, North Carolina, United States

Clemson Rural Health

Clemson, South Carolina, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06610474


Related Trials